HealthCare Royalty Partners
Overview
HealthCare Royalty Partners ("HCR") is a leading royalty acquisition company focused on commercial or near-commercial stage biopharmaceutical products. HCR has raised over $6.2 billion in cumulative c…
Investment Focus
- Assets with significant clinical value
- Strong barriers to entry
- Sustainable revenues over extended periods
- Alignment with marketer's objectives
Portfolio Companies
Get the full list of 54,000+ investors
HealthCare Royalty Partners and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about HealthCare Royalty Partners
What sectors does HealthCare Royalty Partners invest in?
HealthCare Royalty Partners invests in Healthcare, Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Specialty Pharmaceuticals, and is based in Stamford, United States. HealthCare Royalty Partners is listed as a private investment firm in the ConnectSafely investor database.
What stage does HealthCare Royalty Partners invest at?
HealthCare Royalty Partners backs companies at Growth, Late Stage and Pre-IPO, writing cheques of 20M - 200M.
Which regions does HealthCare Royalty Partners invest in?
HealthCare Royalty Partners invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
Who are the partners at HealthCare Royalty Partners?
Team members listed for HealthCare Royalty Partners include Carlos Almodovar (Chief Business Officer) and Andrew Reardon (Chief Legal Officer).
What companies has HealthCare Royalty Partners invested in?
HealthCare Royalty Partners's portfolio includes Johnson & Johnson, Ipsen, Bayer AG, CSL Vifor, Maruishi Pharma, Elanco and Bausch Health Companies.
How do I contact HealthCare Royalty Partners?
HealthCare Royalty Partners's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
